癌症幸存者口头记忆的过程模型:贝叶斯过程建模方法对测试成绩的变化
Ruben D Potthoff1, Sanne B Schagen1,2, Joost A Agelink van Rentergem1
1Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Journal of clinical and experimental neuropsychology
|February 7, 2024
概括
癌症幸存者表现出微妙的口头记忆缺陷,特别是在即时回忆中,使用新的贝叶斯过程模型. 这种先进的分析揭示了传统分数中的过程变化和不确定性,为认知功能提供了更深入的见解.
科学领域:
- 认知神经科学 认知神经科学
- 神经心理学 神经心理学
- 心理测量 心理测量 心理测量
背景情况:
- 语言记忆对认知至关重要,但传统的测试过度简化了其复杂的过程.
- 癌症及其治疗可以影响认知功能,包括口头记忆.
- 了解这些影响需要细微的分析方法,而不仅仅是简单的总和分数.
研究的目的:
- 研究癌症及其治疗对口头记忆过程的影响.
- 为了证明贝叶斯过程模型在分析神经心理测试数据中的实用性.
- 在口头记忆评估中解决得分和过程变化.
主要方法:
- 使用阿姆斯特丹认知扫描 (ACS) 进行数字化,在家进行认知测试.
- 分析了使用传统总和分数和贝叶斯过程模型等同的口头学习测试数据.
- 与非中枢神经系统癌症幸存者 (n=184) 和无癌症对照组 (n=204) 的比较.
主要成果:
- 总分数分析显示,癌症幸存者立即回忆率较低,但延迟回忆率没有差异.
- 贝叶斯过程模型表明,群体之间在即时检索 (部分学习和学习状态) 中存在微妙的差异.
- 在学习或延迟检索过程中没有发现显著差异;过程模型显示的不确定性低于检索总分.
结论:
- 贝叶斯过程模型通过量化不确定性来增强口头学习测试数据的信息性.
- 这些模型揭示了癌症幸存者和对照者之间潜在的记忆过程的差异.
- 该方法提供了对个体记忆过程及其变异性的洞察.
相关概念视频
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Modeling in Therapy
79
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
79
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Actuarial Approach
79
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
79
Kaplan-Meier Approach
141
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
141


